A case of thyrotoxicosis after sunitinib treatment |
Ho Young Lee, Mi Kyung Kim, Nam Keong Kim, Hye Soon Kim, Seong-Yeol Ryu, Ki Young Kwon, Keun Gyu Park |
|
Sunitinib 치료 이후 발생한 갑상선중독증 1예 |
이호영, 김미경, 김남경, 김혜순, 류성열, 권기영, 박근규 |
|
|
|
Abstract |
Sunitinib is a tyrosine-kinase inhibitor used to treat metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors. Hypothyroidism is a common side effect of sunitinib therapy. Nevertheless, overt thyrotoxicosis induced by destructive thyroiditis after sunitinib treatment is very rare. Here, we report a patient with overt thyrotoxicosis related to sunitinib therapy. |
Key Words:
Sunitinib; Thyrotoxicosis |
|